Interested in Cartistem Study At Rush University Medical Center? On this page, we have collected links for you, where you will receive the most necessary information about Cartistem Study At Rush University Medical Center.
https://clinicaltrials.gov/ct2/show/NCT01733186
Nov 26, 2012 · CARTISTEM®, a combination of human umbilical cord blood-derived mesenchymal stem cells and sodium hyaluronate, is intended to be used as a single-dose cellular therapeutic agent for cartilage regeneration in human subjects with cartilage defects of the knee as a result of ageing, trauma, or degenerative diseases.
https://www.sciencedaily.com/releases/2013/01/130124163246.htm
Jan 24, 2013 · Rush University Medical Center is conducting the nation's first clinical study of an innovative stem cell drug, Cartistem, to repair knee cartilage damaged by aging, trauma or degenerative diseases...
http://www.eurekalert.org/pub_releases/2013-01/rumc-rrs012413.php
(CHICAGO) - Rush University Medical Center is conducting the nation's first clinical study of an innovative stem cell drug, Cartistem, to repair knee cartilage damaged by aging, trauma or...
http://stemcellsfreak.com/2013/01/Cartistem-clinical-trial.html
Jan 25, 2013 · The Rush University Medical Center (RUMC) announced yestesome very good news yesterday, for people with cartilage defects. Specifically, it will soon begin a human clinical trial involving Cartistem, a stem cell product for cartilage regeneration. The phase I/IIa study will last for two years and a total of 12 patients are expected to enrol.
https://medicalxpress.com/news/2013-01-stem-cell-therapy-knee-cartilage.html
Jan 24, 2013 · Rush University Medical Center is conducting the nation's first clinical study of an innovative stem cell drug, Cartistem, to repair knee cartilage damaged by …
https://abc7chicago.com/archive/9059286/
Participants ages 18 and older are needed for the two year study at Rush University Medical Center. ... For information on the Cartistem study at Rush University Medical Center, call (312) 563-2214.
https://centerwatch.com/clinical-trials/listings/condition/751/cartilage-injuries/
A Follow-up Study of CARTISTEM Versus Microfracture This is a multi-center, medium/long-term follow-up study of CARTISTEM® versus Microfracture for the treatment of knee articular cartilage injury or defect. The study is phase III, and 123 views
We hope you have found all the information you need about Cartistem Study At Rush University Medical Center through the links above.
